MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Award Announcements & Progress Reports: Federal Contracts, Grants & Cooperative Agreements
*2018: SDVOSB Awardees_CIO-SP3 Small Business Ramp On Open Season_Solicitation Number NIHJT2016015, Award
TechWerks, LLC (technologywerks) (SDVOSB)
San Antonio, Texas
2026: OPMED 2026_Operational Medicine (OpMed) SYMPOSIUM & TECHNOLOGY SHOWCASE March 17-18 2026, San Antonio, Texas
Organon & Co. (NYSE:OGN)*
Finance & Acquisitions: Organon
Forendo Pharma
Parents
Companies: Acquired_(M&A)
Finance & Acquisitions: Organon
Porfolio Companies: Novo Nordisk
Children
* Its lead clinical compound is an investigational, potentially first-in-class oral 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1) inhibitor in early clinical development for endometriosis, being evaluated for its potential effect on endometriotic lesions.
*Architects: Obstetrics, Gynecology (OB/GYN) _ Women's Health, Maternal, Pregnancy, Menopause
*Forendo is pioneering the science of intracrinology, addressing disease through a novel, tissue-specific approach.
2021: Organon to Acquire Forendo Pharma